No Data
Glory Health Industry Sets Out Board and Committee Structure
Glory Health Industry Tightens Governance With Revised Nomination Committee Charter
Guorui Health (02329) appointed Yuan Haibin and Zhang Xiaoqian as Executive Directors.
Guorui Health (02329) announced that, effective June 2, 2026, Mr. Yang Huabin and Mr. Feng Yang have resigned as executive directors due to other work commitments, and Mr. Yuan Haibin and Ms. Zhang Xiaoqian have been appointed as executive directors.
GLORY HEALTH: 2025 Annual Report
Guorui Health (02329) announced its 2025 financial results, with a net loss attributable to owners of approximately 1.822 billion yuan, representing a year-on-year increase of 46.92%.
Guorui Health (02329) announced its 2025 financial results, with total revenue of approximately 1.036 billion yuan, representing a year-on-year decrease of 61.72%. The loss attributable to the company's owners was approximately 1.822 billion yuan, reflecting a year-on-year increase of 46.92%. The loss per share was 0.41 fen.
Express News | Glory Health Industry FY Revenue RMB 1,035.6 Million